# A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients with Chronic Kidney Disease-Associated Pruritus

> **NCT05135390** · PHASE3 · COMPLETED · sponsor: **Haisco Pharmaceutical Group Co., Ltd.** · enrollment: 545 (actual)

## Conditions studied

- Pruritus
- Hemodialysis Patients with Moderate-to-Severe Pruritus

## Interventions

- **DRUG:** HSK21542
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05135390
- **Lead sponsor:** Haisco Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-17
- **Primary completion:** 2023-07-27
- **Final completion:** 2024-06-06
- **Target enrollment:** 545 (ACTUAL)
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135390, "A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients with Chronic Kidney Disease-Associated Pruritus". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05135390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*